[Meloxicam clinical effects]

Area of Science:

• Pharmacology
• Pain Management
• Rheumatology

Background:

• Pain syndromes, including those from osteoarthritis and rheumatoid arthritis, necessitate increased use of nonsteroidal anti-inflammatory drugs (NSAIDs).
• Selecting the safest NSAID involves assessing toxicity (cyclooxygenase inhibition) and benefit-risk ratios, considering individual sensitivities and pre-existing conditions like gastrointestinal or cardiovascular diseases.
• NSAID use is often limited by potential adverse events and chronic health conditions such as type 2 diabetes mellitus.

Purpose of the Study:

• To recommend meloxicam as a safe and effective NSAID for diverse pain syndromes.
• To review the efficacy and safety of meloxicam across various administration routes.
• To highlight current therapeutic strategies involving meloxicam.

Main Methods:

• Review of existing studies on meloxicam's efficacy and safety.
• Analysis of different administration methods: oral (p/o), intramuscular (i/m), and intravenous (i/v).
• Examination of pain management protocols involving meloxicam, including combination therapies.

Main Results:

• Meloxicam has demonstrated efficacy and safety in treating pain associated with lower back pain and osteoarthritis via oral and intramuscular routes.
• Recent research supports the use of intravenous meloxicam (30 mg) for moderate to severe postoperative pain.
• Common treatment regimens involve initial intramuscular administration followed by oral meloxicam, or combination therapy with muscle relaxants and B vitamins.

Conclusions:

• Meloxicam is a recommended NSAID for managing various pain syndromes due to its established efficacy and safety profile.
• Step-by-step administration, transitioning from injectable to oral forms, is a common and effective therapeutic scheme.
• Combination therapy with muscle relaxants and B vitamins may enhance pain management outcomes.